Entry Point Capital, LLC Ptc Therapeutics, Inc. Transaction History
Entry Point Capital, LLC
- $171 Million
- Q3 2024
A detailed history of Entry Point Capital, LLC transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Entry Point Capital, LLC holds 8,836 shares of PTCT stock, worth $378,976. This represents 0.19% of its overall portfolio holdings.
Number of Shares
8,836
Previous 4,055
117.9%
Holding current value
$378,976
Previous $124 Million
99.74%
% of portfolio
0.19%
Previous 0.18%
Shares
4 transactions
Others Institutions Holding PTCT
# of Institutions
222Shares Held
78.1MCall Options Held
144KPut Options Held
58.7K-
Vanguard Group Inc Valley Forge, PA9.13MShares$391 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA7.89MShares$339 Million0.05% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$333 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.39MShares$317 Million4.37% of portfolio
-
Armistice Capital, LLC New York, NY7.23MShares$310 Million4.46% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $3.07B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...